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RECEPTOR RESERVE

Behavioral Effects of
Irreversible Dopamine
Receptor Inactivation
in the Preweanling Rat:
Assessment of the Receptor
Reserve Hypothesis
Suzanne L. Reid and Sanders A.
McDougall
California State University, San
Bernardino
Abstract
EEDQ is an irreversible receptor antagonist
that eliminates the dopamine (DA) mediated
behaviors of adults rats. In contrast,
EEDQ does not seem to affect the DA
mediated behaviors of preweanling rat
pups. One explanation for this agedependent difference is that rat pups may
have a DA receptor reserve, not available to
adults, which is sufficient to mediate
behavior. Therefore, the purpose of the
present study was to determine whether a
Di and D2 receptor reserve exists in
preweanling rats. A total of 96, 17-dayold rat pups were injected with EEDQ (7.5
mg/kg) or its vehicle immediately after
being trained to approach an anesthetized
dam on a straight alley for nipple
attachment reward. After 18 hours rat pups
were then injected with saline, the D1
agonist SCH 23390 (0.5 mg1kg), or the D2
agonist sulpiride (50 mg/kg). A final
testing session occurred 30 min later. This
session consisted of an additional 28 trials
on the straight alley, in which responding
resulted in either reinforcement or
extinction. Results of this experiment
indicated that EEDQ and SCH 23390
combined to maximally disrupt the
extinction responding of the rat pups.
Unexpectedly, EEDQ did not potentiate
sulpiride's effects. In general, these
results indicate that preweanling rat pups
do not have a DI or D2 receptor reserve,
but age-dependent differences in DA
receptor functioning were apparent.
Biochemical studies have shown
that dopamine (DA) receptors can be

divided into a number of distinct subtypes:
D 1, Des, D21, D3, D4, and D5 (Chio,
Hess, Graham, & Huff, 1990; Sokoloff,
Giros, Martes, Bouthenet, & Schwartz,
1990; Sunahara et al., 1991; Van Tol et al.,
1991). The psychopharmacological
characteristics of these receptor subtypes
are only partially understood, as the
behavioral actions of just the D1 and D2
receptors have been studied intensively.
For example, selective D2 agonists (e.g.,
quinpirole and bromocriptine) increase the
locomotor activity, rearing, and sniffing of
preweanling and adult rats (Arnt, 1987;
McDougall, Arnold, & Nonneman, 1990;
McDougall, Crawford, & Nonneman,
1993). Conversely, selective D1 agonists
(e.g., SKF 38393) have only a few
behavioral effects, the most prominent
among them being a dose-dependent
increase in grooming (McDougall et al.,
1990, 1993; Molloy & Waddington, 1985;
Murray & Waddington, 1989). Blocking
these D1 and D2 receptors has predictable
actions, as reversible DA antagonists (e.g.,
SCH 23390 and sulpiride) eliminate the
agonist-induced behaviors of both rat pups
and adults (Arnt, 1987; McDougall et al.,
1990). When considered together, these
studies indicate that D1 and D2 receptors
mediate different behaviors and that
treatment with reversible DI and D2
agonists and antagonists induce similar
behavioral effects in preweanling and adult
rats.
In contrast, studies using the
irreversible
receptor
antagonist
N- ethoxycarbonyl- 2- ethoxy- 1, 2dihydroquinoline (EEDQ) indicate that the
D1 and D2 receptor systems of preweanling
and adult rats differ in a fundamental way.
EEDQ is an alkylating agent that
permanently binds to DA receptors and
inactivates them (Hamblin & Creese,
1983). In adult rats, EEDQ treatment
blocks the behavioral effects normally
induced by selective D2 agonists or
nonselective DA agonists (Arnt, Hyttel, &
Meier, 1988; Cameron & Crocker, 1989;
Giorgi & Biggio, 1990; Hamblin &
Creese, 1983; McDougall, Crawford, &
Nonneman, 1992a; Meller, Bordi, &
Bohmaker, 1989). This behavioral deficit
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is apparently caused by an EEDQ-induced
reduction in D2 receptors, and the resulting
inability of the agonist to bind to a
sufficient number of receptors. After
approximately four days (depending on the
behavior), the agonist is once again able to
induce behavioral effects, presumably
because D2 receptor repopulation is
sufficient to mediate behavior. A
qualitatively different effect is observed in
adult rats after treatment with a D1 agonist,
as EEDQ does not block behaviors induced
by SKF 38393 (Arnt et al., 1988;
Rosengarten, Schweitzer, & Friedhoff,
1989; Yokoo, Goldstein, & Meller, 1988).
This Di/D2 dichotomy is not due to
differential selectivity of EEDQ, because
this irreversible antagonist inactivates
approximately the same percentage of D1
and D2 receptors in adult rats (Arnt et al.,
1988; Crawford, McDougall, Rowlett, &
Bardo, 1992; Crawford, Rowlett,
McDougall, & Bardo, 1994; Hamblin &
Creese, 1983; Saller, Kreamer,
Adamovage, & Salama, 1989).
EEDQ has distinctly different
effects in the preweanling rat. For
example, EEDQ is unable to block either
the D1 or D2 mediated behaviors of 11- and
17-day-old rats (McDougall et al., 1992a,
1993; Mestlin & McDougall, 1993). More
specifically, in the preweanling rat,
treatment with either moderate (7.5 mg/kg)
or high (15.0 mg/kg) doses of EEDQ does
not diminish behaviors induced by SKF
38393 (a D1 agonist), quinpirole (a D2
agonist), or NPA (a nonselective DA
agonist). EEDQ's inability to effect
behavior is not due to a lack of drug
efficacy, because EEDQ inactivates a
substantial percentage (approximately 6369%) of D1 and D2 receptors in the 17day-old rat (Crawford et al., 1992, 1994).
Therefore, when considered together, these
results are consistent with the idea that the
preweanling rat has large reserves of D1
and D2 receptors--reserves which are
sufficient to compensate for the EEDQinduced receptor loss.
In order to determine whether
preweanling rats actually have functional
reserves of Di and D2 receptors, we
trained 17-day-old rats on an appetitive
approach task and then injected them with
2

EEDQ or its vehicle. (The appetitive
approach task was used because this
behavior is very sensitive to DA receptor
blockade (McDougall, Crawford, &
Nonneman, 1992b; McDougall,
Nonneman, & Crawford, 1991]). One day
later, pups were given either the DI
antagonist SCH 23390, the D2 antagonist
sulpiride, or saline, 30 minutes prior to
reinforcement or extinction testing. If the
receptor reserve hypothesis is correct,
SCH 23390 and sulpiride should only
moderately diminish the extinction and
reinforced responding of the non-EEDQtreated rat pups. In contrast, the same DA
antagonists should more severely disrupt
the extinction and reinforced responding of
the EEDQ-pretreated rat pups, because the
reserve of DA receptors was already
inactivated by EEDQ.
Method
Subjects and rearing procedures
Subjects were 96 male and female
rats of Sprague-Dawley descent (Harlan
Sprague Dawley, Inc., Indianapolis, IN)
tested when 16 and 17 days of age. Litters
were culled to a maximum of 10 pups or a
minimum of 8 pups at three days of age.
Rat pups were kept with the dam until
initial isolation 16 hours before testing.
Assignment of subjects to groups was
random according to gender and within
each litter. The colony room was
maintained at 23-250 C and kept under a
14:10-hour light-dark cycle. Behavioral
testing was conducted during the light
phase of the cycle.
Apparatus
The testing apparatus was a straight
alley (40 X 8 X 15 cm) with start and goal
boxes (15 X 15 X 15 cm) located at either
end. The alley and goal box were painted
black and the start box was painted gray.
Clear Plexiglas basket cages (45 X 21 X
24 cm) that contained hardwood chipped
bedding were used as isolation cages and
intertrial interval (ITI) chambers. The
isolation cages, ITI chambers, and straight
alley were located in a separate
experimental room. Both the isolation
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cages and the ITI chambers were placed on
heating pads so that the rat pups could be
maintained at 330 C, which is approximate
thermoneutrality for pups between 10 and
20 days of age (Conklin & Heggeness,
1971).
Procedure
Approximately 16 hours before
testing, rat pups were removed from their
mother and placed in an isolation cage
without food or water being available.
After this 16 hour isolation period, the rat
pup was placed in the goal box of the
straight alley and allowed 15 seconds of
nipple attachment to an anesthetized
lactating dam. Anesthetization and
blockade of milk production were
produced by injections of L. A. Thesia
(chloral hydrate [60 mg/mi] and sodium
pentobarbital [30 mg/mi]) starting 20
minutes before testing. After the initial 15
seconds of nipple attachment, the rat pup
was placed in the start box for the
beginning of acquisition training. If the rat
pup did not traverse the start box and alley
after 60 seconds, then it was gently forced
down the alley to the goal box. In either
case, a 15 second nipple attachment reward
was provided and followed by a 15 second
placement in the ITT chamber. Acquisition
of the approach response consisted of two,
eight trial acquisition sessions that were
separated by a 5 minutes placement in the
ITI chamber.
The rat pups were returned to their
home cages for 4 hours and then injected
intraperitoneally (ip) with either EEDQ (7.5
mg/kg) or its vehicle. (EEDQ was
dissolved in 95% ethanol:distilled water
[1:4] and was given at a volume of 5
ml/kg.) After an additional 18 hour of
isolation, the 17-day-old rats were injected
ip (5 ml/kg) with SCH 23390 (0.5 mg/kg),
sulpiride (50 mg/kg), or saline 30 minutes
before a final testing session. (Sulpiride
and SCH 23390 were dissolved in saline,
with the former drug requiring a small
volume of glacial acetic acid.) The final
testing session consisted of four
acquisition trials followed by either 28
reinforcement trials (responding resulted in
15 second confinement with the dam) or 28

extinction trials (responding resulted in 15
second confinement in the empty goal
box). During the testing session, the rat
pup was not forced down the alley for
nonresponding; rather, after 60 seconds it
was given a 15 second placement in the ITI
chamber.
Analyses of variance (ANOVAs)
with repeated measures were used for
statistical analysis of mean latencies to
traverse the maze. The ANOVAs were
performed across blocks of four trials.
Significant two-and three-way interactions
were further analyzed using lower order
ANOVAs and Tukey tests (p <.05).
Results
Extinction responding
Mean latencies to traverse the maze
during the single extinction session are
presented in Figure 1. Across the initial
block of four trials, rat pups receiving both
EEDQ and sulpiride had significantly
longer response latencies than all other
group, Pre X Post interaction, F (2, 42) =
3.96, p < .05, and Tukey tests (p < .05).
In addition, the EEDQ/SCH 23390 groups
showed enhanced latencies relative to the
VEHICLE/SALINE and VEHICLE/SCH
23390 controls, Pre X Post interaction.
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BLOCKS OF FOUR TRIALS

Figure I. Mean response latencies per trial across
blocks of four trials for 17-day-old rat pups injected
with EEDQ (7.5 mg/kg) or its vehicle 18 hr prior to
the extinction session. The EEDQ and vehicle groups
were further subdivided with rat pups being injected
with either saline, sulpiride (50 mg/kg), or SCH
23390 (0.5 mg/kg) 30 min prior to extinction
testing.
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Overall, when collapsed across the
remaining seven blocks of trials, rat pups
receiving EEDQ had longer response
latencies than pups receiving vehicle, pre
main effect, F (1, 42) = 6.90, p < .05; and
rat pups injected with sulpiride or SCH
23390 had longer latencies than those pups
given saline, post main effect, F (2, 42) =
8.52, p < .05, and Tukey tests (p < .05).
More specifically, on Blocks 3-8, rat pups
receiving both EEDQ and SCH 23390 had
longer response latencies than pups in the
VEHICLE/SCH 23390 group, Pre X Post
X Block interaction, F (12, 252) = 3.11,
p < .05, and Tukey tests (p<.05). Rat pups
in the EEDQ/SULPIRIDE group also had
longer response latencies than pups in the
VEHICLE/SULPIRIDE group, but only
on the second block of the extinction
session, Pre X Post X Block interaction.
Interestingly, rats receiving EEDQ alone
(i.e. the EEDQ/SALINE group) had longer
latencies than rats in the
VEHICLE/SALINE group. The
differences between these two groups were
significant on Blocks 3, 6, 7, and 8, Pre X
Post X Block interaction. Importantly, rat
pups in the EEDQ/SALINE group had
significantly shorter response latencies than
pups from the EEDQ/SULPIRIDE and
EEDQ/SCH 23390 groups.
Reinforced responding
Mean latencies to traverse the maze
during the single reinforcement session are
presented in Figure 2. The reinforced
responding of the various groups of rat
pups did not vary on the first block of
trials. On the subsequent seven blocks of
trials, rat pups receiving sulpiride or SCH
23390 had significantly longer response
latencies than pups given saline, post main
effect, F (2, 42) = 7.34, p < .05, and
Tukey tests (p < .05). This effect varied
across blocks, as the differences between
the saline-treated rat pups and the SCH
23390-and sulpiride-treated pups were
only apparent on Blocks 4-8, Post X Block
interaction, F (12, 252) = 2.18, p < .05,
and Tukey tests (p < .05). None of the
interactions involving EEDQ and vehicle as
a variable were significant.
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Figure 2. Mean response latencies per trial across
blocks of four trials for 17-day-old rat pups injected
with EEDQ (7.5 mg/kg) or its vehicle 18 hr prior to
the reinforcement session. The EEDQ and vehicle
groups were further subdivided with rat pups being
injected with either saline, sulpiride (50 mg/kg), or
SCH 23390 (0.5 mg/kg) 30 min prior to
reinforcement testing.

General Discussion
Previous studies have shown that
EEDQ does not block the DI and D2
mediated behaviors of preweanling rats
(McDougall et al., 1992a, 1993; Mestlin &
McDougall, 1993). Consistent with this,
in the present study, EEDQ did not affect
the reinforced responding of 17-day-old
rats (see Figure 2). In contrast, EEDQ did
increase the response latencies of rat pups
tested during extinction (see Figure 1).
Importantly, rat pups treated with both
SCH 23390 and EEDQ had longer
extinction latencies than pups given either
EEDQ or SCH 23390 alone. Sulpiride
also affected extinction responding,
however EEDQ did not potentiate
sulpiride's effects.
In general, the present results
suggest that the DI receptors mediating
extinction responding do not have an
appreciable receptor reserve.
More
specifically, an EEDQ-induced reduction of
DA receptors was sufficient to increase the
extinction latencies of the rat pups. This
indicates that a reserve of DI receptors was
not available to replace those lost to EEDQ.
However, it is important to realize that
SCH 23390 did potentiate EEDQ's actions,
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which was expected since both drugs effect
the D1 receptor. In contrast, there appears
to be a D1 receptor reserve for reinforced
responding, since EEDQ alone did not
affect this behavior. It is unclear why the
extinction and reinforced responding of
preweanling rats was differentially affected
by EEDQ; however, it is possible that
extinction and reinforced responding are
mediated by different populations of DA
receptors. Alternatively, it is also possible
that extinction responding is simply a more
sensitive measure of performance and was
better able to detect drug-induced effects.
Unexpectedly, there was no
evidence for a D2 receptor reserve when
either extinction or reinforced responding
was assessed. For example, sulpiride
disrupted the extinction and reinforced
responding of the rat pups, but at no time
did sulpiride and EEDQ combine to
maximally disrupt responding. This is
entirely consistent with other studies
showing that EEDQ is unable to block the
D 2 mediated locomotor activity,
stereotyped sniffing, and rearing of
preweanling rats (McDougall et al., 1992a,
1993; Mestlin & McDougall, 1993). Of
course, similar studies using adult rats
have shown that EEDQ will eliminate D2
mediated behaviors (Arnt et al., 1988;
Cameron & Crocker, 1989; Giorgi &
Biggio, 1990; Hamblin & Creese, 1983;
McDougall et al., 1992a; Meller et al.,
1989). The reason for this age-dependent
difference is uncertain, but it is apparently
not due to a lack of drug efficacy or quick
repopulation rates. More specifically, the
D2 receptors of preweanling rats are
reduced by at least 60% when assayed 24
hours after EEDQ treatment. Importantly,
this level of depletion is sufficient to
significantly disrupt the behaviors of adult
rats (Crawford et al., 1992, 1994;
McDougall et al., 1992a). More
generally, it remains uncertain why an
irreversible DA receptor antagonist (EEDQ)
did not potentiate the effects of a reversible
D2 receptor antagonist (sulpiride).
Previously we have shown that two
reversible antagonists will combine to
maximally disrupt the behaviors of
preweanling rats (McDougall et al., 1991,
1992b). Likewise, Wanibuchi and Usuda

(1990) found that YM-09151 (a reversible
D2 antagonist) would potentiate SCH
23390-induced catalepsy in the adult rat.
Thus, it is unclear why the present results
were obtained. One possibility is that
EEDQ and sulpiride were affecting
different receptor subpopulations, perhaps
within a particular brain region or even
within a given population of neurons. The
same explanation may also account for
why EEDQ did not affect D1 mediated
locomotor activity or grooming
(McDougall et al., 1993), whereas EEDQ
did affect D1 mediated extinction
responding (see Figure 1). More
specifically, those brain areas (e.g. the
striatum) mediating locomotor activity are
probably different from those brain areas
(e.g. the nucleus accumbens and other
limbic structures) mediating learned
behaviors (Bordi, Carr, & Meller, 1989;
Cameron & Crocker, 1989). Not
surprisingly, the availability of reserve
receptors varies according to the receptor
population being assessed (Meller, Enz, &
Goldstein, 1988; Yokoo et al., 1988), so
EEDQ's differential effects may be due to
the characteristics of those receptor
populations mediating a particular
behavior.
A number of studies have shown
that EEDQ preferentially binds to D1 and
D2 receptors, but will, to a lesser extent,
also bind to a-adrenergic, serotonin, and
GABA receptors (Meller, Bohmaker,
Goldstein, & Friedhoff, 1985; Miller,
Lumpkin, Galpern, Greenblatt, & Shader,
1991). To control for the lack of EEDQ
specificity, some researchers selectively
protect D1 and D2 receptors by pretreating
rats with SCH 23390 and sulpiride and
then comparing those groups to saline
pretreated controls (i.e., groups
specifically depleted of nondopaminergic
receptors are compared to groups depleted
of both nondopaminergic and
dopaminergic receptors) (Cameron &
Crocker, 1989; Hamblin & Creese, 1983;
McDougall et al., 1992a). In the present
study, DA receptors were not selectively
protected because we have previously
shown that rat pups given protection
pretreatment and EEDQ respond similarly
to pups given vehicle alone (McDougall et
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al., 1992a, 1993).
In summary, EEDQ alone effected
the extinction responding of preweanling
rats, indicating the lack of a D1 receptor
reserve for this behavior. In contrast,
EEDQ did not affect the D2 mediated
extinction or reinforced responding of the
17-day-olds. However, the latter result
does not necessarily indicate the presence
of a D2 receptor reserve, because sulpiride
was unable to combine with EEDQ to
maximally disrupt behavior. Rather, these
results may also reflect an age-dependent
difference in the characteristics of DA
receptor functioning.
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